Profiel
Shannon Inman worked as Vice President-Global Clinical Operations at Genprex, Inc. from 2020 to 2021.
Prior to that, she worked as Vice President-Global Clinical Operations at Kuur Therapeutics Ltd.
She also worked as a Project Manager at Baylor College of Medicine.
In terms of education, Inman received an undergraduate degree from Texas A&M University.
Eerdere bekende functies van Shannon Inman
| Bedrijven | Functie | Einde |
|---|---|---|
| GENPREX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2021 |
| Baylor College of Medicine | Corporate Officer/Principal | - |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Shannon Inman
| Texas A&M University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENPREX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
